Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease

Frontiers in Bioscience

Volumn 14, Issue 3, 2009, Pages 1152-1168

  Lepoutre, Veronique ^a   Jain, Pooja ^a   Quann, Kevin ^a   Wigdahl, Brian ^a   Khan, Zafar K ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cns; Csf; Ham; Htlv 1; Review; Tsp; Virus

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

CENTRAL NERVOUS SYSTEM; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; ISOLATION AND PURIFICATION; MUSCLE DISEASE; PATHOLOGY; REVIEW; SPASTIC PARAPLEGIA;

CENTRAL NERVOUS SYSTEM; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MUSCULAR DISEASES; PARAPARESIS, TROPICAL SPASTIC;

EID: 63849344060     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3300     Document Type: Article

References (181)

1. Y. Hinuma, H. Komoda, T. Chosa, T. Kondo, M. Kohakura, T. Takenaka, M. Kikuchi, M. Ichimaru, K. Yunoki, I. Sato, R. Matsuo, Y. Takiuchi, H. Uchino and M. Hanaoka: Antibodies to adult T-cell leukemia-virusassociated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer, 29 (6), 631-5 (1982). (Pubitemid 12089201)
2. W. A. Blattner, D. W. Blayney, M. Robert-Guroff, M. G. Sarngadharan, V. S. Kalyanaraman, P. S. Sarin, E. S. Jaffe and R. C. Gallo: Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis, 147 (3), 406-16 (1983). (Pubitemid 13163178)
3. W. A. Blattner, V. S. Kalyanaraman, M. Robert-Guroff, T. A. Lister, D. A. Galton, P. S. Sarin, M. H. Crawford, D. Catovsky, M. Greaves and R. C. Gallo: The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer, 30 (3), 257-64 (1982). (Pubitemid 12026962)
4. W. C. Reeves, C. Saxinger, M. M. Brenes, E. Quiroz, J. W. Clark, M. W. Hoh and W. A. Blattner: Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panama. Am J Epidemiol, 127 (3), 532-9 (1988). (Pubitemid 18072869)
5. E. M. Maloney, H. Ramirez, A. Levin and W. A. Blattner: A survey of the human T-cell lymphotropic virus type I (HTLV-I) in south-western Colombia. Int J Cancer, 44 (3), 419-23 (1989). (Pubitemid 19229297)
6. W. Saxinger, W. A. Blattner, P. H. Levine, J. Clark, R. Biggar, M. Hoh, J. Moghissi, P. Jacobs, L. Wilson, R. Jacobson and et al.: Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science, 225 (4669), 1473-6 (1984). (Pubitemid 14033130)
7. G. de-The, C. Giordano, A. Gessain, W. Howlett, T. Sonan, F. Akani, H. Rosling, H. Carton, Y. Mouanga, C. Caudie and et al.: Human retroviruses HTLV-I, HIV-1, and HIV-2 and neurological diseases in some equatorial areas of Africa. J Acquir Immune Defic Syndr, 2 (6), 550-6 (1989). (Pubitemid 20017258)
8. B. J. Poiesz, F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna and R. C. Gallo: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A, 77 (12), 7415-9 (1980). (Pubitemid 11131140)
9. G. de The and R. Bomford: An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses, 9 (5), 381-6 (1993).
10. R. F. Edlich, L. G. Hill and F. M. Williams: Global epidemic of human T-cell lymphotrophic virus type-I (HTLVI): an update. J Long Term Eff Med Implants, 13 (2), 127-40 (2003). (Pubitemid 36554782)
11. P. Hollsberg and D. A. Hafler: Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med, 328 (16), 1173-82 (1993). (Pubitemid 23105757)
12. B. Asquith, E. Hanon, G. P. Taylor and C. R. Bangham: Is human T-cell lymphotropic virus type I really silent? Philos Trans R Soc Lond B Biol Sci, 355 (1400), 1013-9 (2000).
13. K. Usuku, S. Sonoda, M. Osame, S. Yashiki, K. Takahashi, M. Matsumoto, T. Sawada, K. Tsuji, M. Tara and A. Igata: HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol, 23 Suppl, S143-50 (1988).
14. S. Daenke, S. Nightingale, J. K. Cruickshank and C. R. Bangham: Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol, 64 (3), 1278-82 (1990). (Pubitemid 20087768)
15. M. Nishimura, D. E. McFarlin and S. Jacobson: Sequence comparisons of HTLV-I from HAM/TSP patients and their asymptomatic spouses. Neurology, 43 (12), 2621- 4 (1993). (Pubitemid 24004556)
16. S. Niewiesk, S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale and C. R. Bangham: The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol, 68 (10), 6778-81 (1994). (Pubitemid 24294933)
17. C. Grant, K. Barmak, T. Alefantis, J. Yao, S. Jacobson and B. Wigdahl: Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol, 190 (2), 133-59 (2002). (Pubitemid 34027818)
18. A. Gessain, F. Saal, O. Gout, M. T. Daniel, G. Flandrin, G. de The, J. Peries and F. Sigaux: High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood, 75 (2), 428-33 (1990). (Pubitemid 20035274)
19. J. Kira, Y. Koyanagi, T. Yamada, Y. Itoyama, I. Goto, N. Yamamoto, H. Sasaki and Y. Sakaki: Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol, 29 (2), 194-201 (1991).
20. R. Kubota, F. Umehara, S. Izumo, S. Ijichi, K. Matsumuro, S. Yashiki, T. Fujiyoshi, S. Sonoda and M. Osame: HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol, 53 (1), 23-9 (1994). (Pubitemid 24249937)
21. J. H. Richardson, A. J. Edwards, J. K. Cruickshank, P. Rudge and A. G. Dalgleish: In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol, 64 (11), 5682-7 (1990). (Pubitemid 20364571)
22. M. Yoshida, M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda and et al.: Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol, 26 (3), 331-5 (1989). (Pubitemid 19230300)
23. A. Q. Araujo and M. T. Silva: The HTLV-1 neurological complex. Lancet Neurol, 5 (12), 1068-76 (2006). (Pubitemid 44709983)
24. A. Gessain and O. Gout: Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med, 117 (11), 933-46 (1992).
25. D. H. McKee, A. C. Young and M. Haeney: Sarcoidosis and HTLV-1 infection. J Clin Pathol, 58 (9), 996-7 (2005). (Pubitemid 41265291)
26. G. R. Moore, U. Traugott, L. C. Scheinberg and C. S. Raine: Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol, 26 (4), 523-30 (1989). (Pubitemid 19247228)
27. M. C. Levin and S. Jacobson: Cellular and humoral immune responses associated with HTLV-I associated myelopathy/tropical spastic paraparesis. Ann N Y Acad Sci, 835, 142-52 (1997). (Pubitemid 28046102)
28. A. Q. Araujo, A. S. Andrade-Filho, C. M. Castro-Costa, M. Menna-Barreto and S. M. Almeida: HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group. J Acquir Immune Defic Syndr Hum Retrovirol, 19 (5), 536-41 (1998).
29. M. Nakagawa, S. Izumo, S. Ijichi, H. Kubota, K. Arimura, M. Kawabata and M. Osame: HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol, 1 (1), 50-61 (1995).
30. H. Shibasaki, C. Endo, Y. Kuroda, R. Kakigi, K. Oda and S. Komine: Clinical picture of HTLV-I associated myelopathy. J Neurol Sci, 87 (1), 15-24 (1988).
31. M. A. Lima, R. B. Bica and A. Q. Araujo: Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. J Neurol Neurosurg Psychiatry, 76 (2), 294-6 (2005). (Pubitemid 40143735)
32. A. Q. Araujo, A. C. Leite, S. V. Dultra and M. J. Andrada-Serpa: Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci, 129 (2), 147-51 (1995).
33. M. Kannagi, H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko and et al.: Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J Virol, 66 (5), 2928-33 (1992).
34. F. Umehara, S. Izumo, M. Nakagawa, A. T. Ronquillo, K. Takahashi, K. Matsumuro, E. Sato and M. Osame: Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol, 52 (4), 424-30 (1993). (Pubitemid 23199203)
35. S. Jacobson, C. S. Raine, E. S. Mingioli and D. E. McFarlin: Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature, 331 (6156), 540-3 (1988). (Pubitemid 18064379)
36. S. Dhawan, B. S. Weeks, F. Abbasi, H. R. Gralnick, A. L. Notkins, M. E. Klotman, K. M. Yamada and P. E. Klotman: Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. Virology, 197 (2), 778-81 (1993).
37. T. Furuya, T. Nakamura, S. Shirabe, Y. Nishiura, A. Tsujino, H. Goto, S. Nakane, K. Eguchi, H. Nakamura and S. Nagataki: Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy. Proc Assoc Am Physicians, 109 (3), 228-36 (1997). (Pubitemid 27209029)
38. T. H. Mogensen and S. R. Paludan: Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev, 65 (1), 131-50 (2001). (Pubitemid 32204291)
39. J. A. Sakai, M. Nagai, M. B. Brennan, C. A. Mora and S. Jacobson: In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. Blood, 98 (5), 1506-11 (2001).
40. S. Jacobson, D. E. McFarlin, S. Robinson, R. Voskuhl, R. Martin, A. Brewah, A. J. Newell and S. Koenig: HTLVI- specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol, 32 (5), 651-7 (1992).
41. M. C. Levin and S. Jacobson: HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neurovirol, 3 (2), 126-40 (1997). (Pubitemid 27182506)
42. L. Cartier and E. Ramirez: Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients. Arch Virol, 150 (4), 743-53 (2005). (Pubitemid 40560822)
43. M. Osame: Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J Neurovirol, 8 (5), 359-64 (2002). (Pubitemid 35446706)
44. K. Barmak, E. W. Harhaj and B. Wigdahl: Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol, 9 (5), 522-9 (2003). (Pubitemid 37279368)
45. C. E. Parker, S. Daenke, S. Nightingale and C. R. Bangham: Activated, HTLV-1-specific cytotoxic Tlymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology, 188 (2), 628-36 (1992).
46. W. E. Biddison, R. Kubota, T. Kawanishi, D. D. Taub, W. W. Cruikshank, D. M. Center, E. W. Connor, U. Utz and S. Jacobson: Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol, 159 (4), 2018-25 (1997). (Pubitemid 127484193)
47. K. Selmaj, C. S. Raine, M. Farooq, W. T. Norton and C. F. Brosnan: Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol, 147 (5), 1522-9 (1991).
48. M. C. Levin, S. M. Lee, F. Kalume, Y. Morcos, F. C. Dohan Jr., K. A. Hasty, J. C. Callaway, J. Zunt, D. Desiderio and J. M. Stuart: Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med, 8 (5), 509-13 (2002). (Pubitemid 34546754)
49. F. Gonzalez-Scarano and J. Martin-Garcia: The neuropathogenesis of AIDS. Nat Rev Immunol, 5 (1), 69-81 (2005). (Pubitemid 40070332)
50. K. Watabe, T. Saida and S. U. Kim: Human and simian glial cells infected by human T-lymphotropic virus type I in culture. J Neuropathol Exp Neurol, 48 (6), 610-9 (1989). (Pubitemid 19257811)
51. T. J. Lehky, C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame and S. Jacobson: Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol, 37 (2), 167- 75 (1995).
52. P. Hivin, G. Gaudray, C. Devaux and J. M. Mesnard: Interaction between C/EBPbeta and Tax down-regulates human T-cell leukemia virus type I transcription. Virology, 318 (2), 556-65 (2004). (Pubitemid 38224299)
53. C. Grant, M. Nonnemacher, P. Jain, D. Pandya, B. Irish, S. C. Williams and B. Wigdahl: CCAAT/enhancer binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation. Virology (2006).
54. C. Grant, P. Jain, M. Nonnemacher, K. E. Flaig, B. Irish, J. Ahuja, A. Alexaki, T. Alefantis and B. Wigdahl: AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation. J Leukoc Biol, 80 (3), 640-50 (2006). (Pubitemid 44835797)
55. R. Wessner, J. Yao and B. Wigdahl: Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer. Leukemia, 11 Suppl 3, 10-3 (1997).
56. W. F. Hickey and H. Kimura: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science, 239 (4837), 290-2 (1988). (Pubitemid 18061496)
57. J. Bauer, I. Huitinga, W. Zhao, H. Lassmann, W. F. Hickey and C. D. Dijkstra: The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia, 15 (4), 437-46 (1995).
58. Y. Koyanagi, Y. Itoyama, N. Nakamura, K. Takamatsu, J. Kira, T. Iwamasa, I. Goto and N. Yamamoto: In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology, 196 (1), 25-33 (1993).
59. L. Santambrogio, S. L. Belyanskaya, F. R. Fischer, B. Cipriani, C. F. Brosnan, P. Ricciardi-Castagnoli, L. J. Stern, J. L. Strominger and R. Riese: Developmental plasticity of CNS microglia. Proc Natl Acad Sci U S A, 98 (11), 6295-300 (2001). (Pubitemid 32488233)
60. T. Town, V. Nikolic and J. Tan: The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation, 2, 24 (2005).
61. H. G. Fischer and G. Reichmann: Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol, 166 (4), 2717-26 (2001). (Pubitemid 32173513)
62. V. H. Perry, P. B. Andersson and S. Gordon: Macrophages and inflammation in the central nervous system. Trends Neurosci, 16 (7), 268-73 (1993). (Pubitemid 23168847)
63. G. W. Kreutzberg: Microglia: a sensor for pathological events in the CNS. Trends Neurosci, 19 (8), 312-8 (1996). (Pubitemid 26349059)
64. M. J. Carson and J. G. Sutcliffe: Balancing function vs. self defense: the CNS as an active regulator of immune responses. J Neurosci Res, 55 (1), 1-8 (1999). (Pubitemid 29014405)
65. M. Abe, F. Umehara, R. Kubota, T. Moritoyo, S. Izumo and M. Osame: Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J Neurol, 246 (5), 358-64 (1999). (Pubitemid 29261424)
66. P. M. Hoffman, S. Dhib-Jalbut, J. A. Mikovits, D. S. Robbins, A. L. Wolf, G. K. Bergey, N. C. Lohrey, O. S. Weislow and F. W. Ruscetti: Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc Natl Acad Sci U S A, 89 (24), 11784-8 (1992). (Pubitemid 23004728)
67. H. Hara, M. Morita, T. Iwaki, T. Hatae, Y. Itoyama, T. Kitamoto, S. Akizuki, I. Goto and T. Watanabe: Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Exp Med, 180 (3), 831-9 (1994).
68. Y. Kuroda, M. Matsui, M. Kikuchi, K. Kurohara, C. Endo, M. Yukitake, Y. Matsuda, O. Tokunaga, A. Komine-Sakaki and R. Kawaguchi: In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy. Neurology, 44 (12), 2295-9 (1994). (Pubitemid 24382726)
69. T. Moritoyo, T. A. Reinhart, H. Moritoyo, E. Sato, S. Izumo, M. Osame and A. T. Haase: Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol, 40 (1), 84-90 (1996). (Pubitemid 26250146)
70. S. Dhib-Jalbut, P. M. Hoffman, T. Yamabe, D. Sun, J. Xia, H. Eisenberg, G. Bergey and F. W. Ruscetti: Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol, 36 (5), 787-90 (1994). (Pubitemid 24337640)
71. P. J. Magistretti and L. Pellerin: Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex, 6 (1), 50-61 (1996).
72. G. Gegelashvili and A. Schousboe: High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol, 52 (1), 6-15 (1997). (Pubitemid 27318612)
73. N. R. Sibson, A. Dhankhar, G. F. Mason, K. L. Behar, D. L. Rothman and R. G. Shulman: In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci U S A, 94 (6), 2699-704 (1997).
74. F. Aloisi, F. Ria and L. Adorini: Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today, 21 (3), 141-7 (2000).
75. P. Banerjee, R. Rochford, J. Antel, G. Canute, S. Wrzesinski, M. Sieburg and G. Feuer: Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells. J Virol, 81 (4), 1690-700 (2007). (Pubitemid 46214444)
76. R. Szymocha, H. Akaoka, M. Dutuit, C. Malcus, M. Didier-Bazes, M. F. Belin and P. Giraudon: Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha. J Virol, 74 (14), 6433-41 (2000). (Pubitemid 30429810)
77. J. Weber, P. Clapham, J. McKeating, M. Stratton, E. Robey and R. Weiss: Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. J Gen Virol, 70 ( Pt 10), 2653-60 (1989). (Pubitemid 19248812)
78. F. Sabri, E. Tresoldi, M. Di Stefano, S. Polo, M. C. Monaco, A. Verani, J. R. Fiore, P. Lusso, E. Major, F. Chiodi and G. Scarlatti: Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology, 264 (2), 370-84 (1999).
79. F. Chiodi, S. Fuerstenberg, M. Gidlund, B. Asjo and E. M. Fenyo: Infection of brain-derived cells with the human immunodeficiency virus. J Virol, 61 (4), 1244-7 (1987). (Pubitemid 17044040)
80. P. R. Clapham, J. N. Weber, D. Whitby, K. McIntosh, A. G. Dalgleish, P. J. Maddon, K. C. Deen, R. W. Sweet and R. A. Weiss: Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature, 337 (6205), 368-70 (1989). (Pubitemid 19043500)
81. M. Neumann, B. K. Felber, A. Kleinschmidt, B. Froese, V. Erfle, G. N. Pavlakis and R. Brack-Werner: Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol, 69 (4), 2159-67 (1995).
82. C. Tornatore, A. Nath, K. Amemiya and E. O. Major: Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor (s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol, 65 (11), 6094-100 (1991).
83. S. Kramer-Hammerle, I. Rothenaigner, H. Wolff, J. E. Bell and R. Brack-Werner: Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res, 111 (2), 194-213 (2005). (Pubitemid 40909736)
84. T. J. Lehky, E. P. Cowan, L. A. Lampson and S. Jacobson: Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J Virol, 68 (3), 1854-63 (1994). (Pubitemid 24065756)
85. T. J. Lehky and S. Jacobson: Induction of HLA class II in HTLV-I infected neuronal cell lines. J Neurovirol, 1 (2), 145- 56 (1995).
86. K. W. Wucherpfennig: Infectious triggers for inflammatory neurological diseases. Nat Med, 8 (5), 455-7 (2002). (Pubitemid 34546745)
87. C. R. Bangham and M. Osame: Cellular immune response to HTLV-1. Oncogene, 24 (39), 6035-46 (2005). (Pubitemid 43086121)
88. E. P. Cowan, R. K. Alexander, S. Daniel, F. Kashanchi and J. N. Brady: Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax. J Virol, 71 (9), 6982-9 (1997). (Pubitemid 27355363)
89. I. Griffiths, M. Klugmann, T. Anderson, D. Yool, C. Thomson, M. H. Schwab, A. Schneider, F. Zimmermann, M. McCulloch, N. Nadon and K. A. Nave: Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science, 280 (5369), 1610-3 (1998). (Pubitemid 28278256)
90. B. D. Trapp, J. Peterson, R. M. Ransohoff, R. Rudick, S. Mork and L. Bo: Axonal transection in the lesions of multiple sclerosis. N Engl J Med, 338 (5), 278-85 (1998). (Pubitemid 28065253)
91. I. Tsunoda and R. S. Fujinami: Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination. Springer Semin Immunopathol, 24 (2), 105-25 (2002). (Pubitemid 35477881)
92. K. W. Selmaj and C. S. Raine: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol, 23 (4), 339-46 (1988). (Pubitemid 18098239)
93. S. D'Souza, K. Alinauskas, E. McCrea, C. Goodyer and J. P. Antel: Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci, 15 (11), 7293-300 (1995).
94. M. Osame, R. Janssen, H. Kubota, H. Nishitani, A. Igata, S. Nagataki, M. Mori, I. Goto, H. Shimabukuro, R. Khabbaz and et al.: Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol, 28 (1), 50-6 (1990). (Pubitemid 20222151)
95. I. J. Koralnik, J. F. Lemp Jr., R. C. Gallo and G. Franchini: In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLVI). AIDS Res Hum Retroviruses, 8 (11), 1845-9 (1992). (Pubitemid 23035486)
96. S. E. Macatonia, J. K. Cruickshank, P. Rudge and S. C. Knight: Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses, 8 (9), 1699-706 (1992).
97. M. Makino, S. Shimokubo, S. I. Wakamatsu, S. Izumo and M. Baba: The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol, 73 (6), 4575-81 (1999). (Pubitemid 29246715)
98. W. J. Livingstone, M. Moore, D. Innes, J. E. Bell and P. Simmonds: Frequent infection of peripheral blood CD8- positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet, 348 (9028), 649-54 (1996). (Pubitemid 26293810)
99. M. C. Levin, M. Krichavsky, R. J. Fox, T. Lehky, S. Jacobson, C. Fox, F. Kleghorn, J. White, N. Young, R. J. Edwards, N. E. Jack and C. Bartholomew: Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease. Blood, 89 (1), 346-8 (1997). (Pubitemid 26428213)
100. G. Feuer, J. K. Fraser, J. A. Zack, F. Lee, R. Feuer and I. S. Chen: Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo. J Virol, 70 (6), 4038-44 (1996). (Pubitemid 26157381)
101. F. Santiago, E. Clark, S. Chong, C. Molina, F. Mozafari, R. Mahieux, M. Fujii, N. Azimi and F. Kashanchi: Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol, 73 (12), 9917-27 (1999).
102. K. Etoh, S. Tamiya, K. Yamaguchi, A. Okayama, H. Tsubouchi, T. Ideta, N. Mueller, K. Takatsuki and M. Matsuoka: Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res, 57 (21), 4862-7 (1997). (Pubitemid 27468995)
103. M. Clerici, N. I. Stocks, R. A. Zajac, R. N. Boswell, D. R. Lucey, C. S. Via and G. M. Shearer: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest, 84 (6), 1892-9 (1989). (Pubitemid 20016195)
104. F. Miedema, A. J. Petit, F. G. Terpstra, J. K. Schattenkerk, F. de Wolf, B. J. Al, M. Roos, J. M. Lange, S. A. Danner, J. Goudsmit and et al.: Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest, 82 (6), 1908-14 (1988). (Pubitemid 19054937)
105. L. K. Musey, J. N. Krieger, J. P. Hughes, T. W. Schacker, L. Corey and M. J. McElrath: Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J Infect Dis, 180 (2), 278-84 (1999). (Pubitemid 30256306)
106. R. J. Gurley, K. Ikeuchi, R. A. Byrn, K. Anderson and J. E. Groopman: CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc Natl Acad Sci U S A, 86 (6), 1993-7 (1989). (Pubitemid 19087054)
107. E. Roilides, M. Clerici, L. DePalma, M. Rubin, P. A. Pizzo and G. M. Shearer: Helper T-cell responses in children infected with human immunodeficiency virus type 1. J Pediatr, 118 (5), 724-30 (1991).
108. H. Groux, G. Torpier, D. Monte, Y. Mouton, A. Capron and J. C. Ameisen: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med, 175 (2), 331-40 (1992).
109. L. Meyaard, S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. Keet and F. Miedema: Programmed death of T cells in HIV- 1 infection. Science, 257 (5067), 217-9 (1992).
110. N. Fan, J. Gavalchin, B. Paul, K. H. Wells, M. J. Lane and B. J. Poiesz: Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J Clin Microbiol, 30 (4), 905-10 (1992).
111. D. Derse, S. A. Hill, P. A. Lloyd, H. Chung and B. A. Morse: Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J Virol, 75 (18), 8461-8 (2001). (Pubitemid 32768950)
112. T. Igakura, J. C. Stinchcombe, P. K. Goon, G. P. Taylor, J. N. Weber, G. M. Griffiths, Y. Tanaka, M. Osame and C. R. Bangham: Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science, 299 (5613), 1713-6 (2003). (Pubitemid 36337193)
113. S. H. Nam, T. D. Copeland, M. Hatanaka and S. Oroszlan: Characterization of ribosomal frameshifting for expression of pol gene products of human T-cell leukemia virus type I. J Virol, 67 (1), 196-203 (1993). (Pubitemid 23002979)
114. I. Le Blanc, M. P. Grange, L. Delamarre, A. R. Rosenberg, V. Blot, C. Pique and M. C. Dokhelar: HTLV-1 structural proteins. Virus Res, 78 (1-2), 5-16 (2001). (Pubitemid 32772819)
115. M. S. Mitchell, J. Tozser, G. Princler, P. A. Lloyd, A. Auth and D. Derse: Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase. J Biol Chem, 281 (7), 3964-71 (2006). (Pubitemid 43847820)
116. M. Nejmeddine, A. L. Barnard, Y. Tanaka, G. P. Taylor and C. R. Bangham: Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem, 280 (33), 29653-60 (2005). (Pubitemid 41177041)
117. J. Overbaugh: HTLV-1 sweet-talks its way into cells. Nat Med, 10 (1), 20-1 (2004). (Pubitemid 38524688)
118. N. Takenouchi, K. S. Jones, I. Lisinski, K. Fugo, K. Yao, S. W. Cushman, F. W. Ruscetti and S. Jacobson: GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1. J Virol, 81 (3), 1506-10 (2007). (Pubitemid 46167872)
119. D. Ghez, Y. Lepelletier, S. Lambert, J. M. Fourneau, V. Blot, S. Janvier, B. Arnulf, P. M. van Endert, N. Heveker, C. Pique and O. Hermine: Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J Virol, 80 (14), 6844-54 (2006). (Pubitemid 44025184)
120. J. E. Hildreth, A. Subramanium and R. A. Hampton: Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology. J Virol, 71 (2), 1173-80 (1997). (Pubitemid 27030289)
121. S. Daenke, S. A. McCracken and S. Booth: Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7. J Gen Virol, 80 ( Pt 6), 1429-36 (1999). (Pubitemid 29261473)
122. P. E. Ceccaldi, F. Delebecque, M. C. Prevost, A. Moris, J. P. Abastado, A. Gessain, O. Schwartz and S. Ozden: DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells. J Virol, 80 (10), 4771-80 (2006).
123. M. Nagai, K. Usuku, W. Matsumoto, D. Kodama, N. Takenouchi, T. Moritoyo, S. Hashiguchi, M. Ichinose, C. R. Bangham, S. Izumo and M. Osame: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol, 4 (6), 586-93 (1998). (Pubitemid 29042065)
124. C. R. Bangham: Human T-cell leukaemia virus type I and neurological disease. Curr Opin Neurobiol, 3 (5), 773- 8 (1993). (Pubitemid 23303384)
125. K. J. Jeffery, K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, A. L. Lloyd, M. A. Nowak, M. Nagai, D. Kodama, S. Izumo, M. Osame and C. R. Bangham: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A, 96 (7), 3848-53 (1999). (Pubitemid 29168999)
126. K. J. Jeffery, A. A. Siddiqui, M. Bunce, A. L. Lloyd, A. M. Vine, A. D. Witkover, S. Izumo, K. Usuku, K. I. Welsh, M. Osame and C. R. Bangham: The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol, 165 (12), 7278-84 (2000). (Pubitemid 32001207)
127. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery and S. Amigorena: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol, 20, 621- 67 (2002). (Pubitemid 34293436)
128. E. Hanon, J. C. Stinchcombe, M. Saito, B. E. Asquith, G. P. Taylor, Y. Tanaka, J. N. Weber, G. M. Griffiths and C. R. Bangham: Fratricide among CD8 (+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity, 13 (5), 657-64 (2000).
129. M. Nagai, M. B. Brennan, J. A. Sakai, C. A. Mora and S. Jacobson: CD8 (+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood, 98 (6), 1858-61 (2001).
130. A. Ali, S. Patterson, K. Cruickshank, P. Rudge, A. G. Dalgleish and S. C. Knight: Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol, 94 (1), 32-7 (1993). (Pubitemid 23308361)
131. D. Wodarz, S. E. Hall, K. Usuku, M. Osame, G. S. Ogg, A. J. McMichael, M. A. Nowak and C. R. Bangham: Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci, 268 (1473), 1215-21 (2001). (Pubitemid 32622374)
132. K. Barmak, E. Harhaj, C. Grant, T. Alefantis and B. Wigdahl: Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology, 308 (1), 1-12 (2003). (Pubitemid 36432113)
133. I. Crenon, C. Beraud, P. Simard, J. Montagne, P. Veschambre and P. Jalinot: The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene. Oncogene, 8 (4), 867-75 (1993). (Pubitemid 23087417)
134. S. Y. Kao and S. J. Marriott: Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J Virol, 73 (5), 4299-304 (1999). (Pubitemid 29189877)
135. C. D. Laherty, N. D. Perkins and V. M. Dixit: Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor kappa B. J Biol Chem, 268 (7), 5032-9 (1993). (Pubitemid 23081627)
136. A. Brauweiler, J. E. Garrus, J. C. Reed and J. K. Nyborg: Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology, 231 (1), 135-40 (1997). (Pubitemid 27238771)
137. M. N. Uittenbogaard, A. P. Armstrong, A. Chiaramello and J. K. Nyborg: Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J Biol Chem, 269 (36), 22466-9 (1994). (Pubitemid 24273344)
138. M. N. Uittenbogaard, H. A. Giebler, D. Reisman and J. K. Nyborg: Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J Biol Chem, 270 (48), 28503-6 (1995).
139. N. Azimi, K. Brown, R. N. Bamford, Y. Tagaya, U. Siebenlist and T. A. Waldmann: Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci U S A, 95 (5), 2452-7 (1998). (Pubitemid 28145962)
140. D. W. Ballard, E. Bohnlein, J. W. Lowenthal, Y. Wano, B. R. Franza and W. C. Greene: HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science, 241 (4873), 1652-5 (1988).
141. L. Good, S. B. Maggirwar and S. C. Sun: Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. Embo J, 15 (14), 3744-50 (1996). (Pubitemid 26239787)
142. J. M. Mariner, V. Lantz, T. A. Waldmann and N. Azimi: Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol, 166 (4), 2602-9 (2001). (Pubitemid 32173498)
143. M. R. Smith and W. C. Greene: Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein. Virology, 187 (1), 316-20 (1992).
144. S. D. Gitlin, P. F. Lindholm, S. J. Marriott and J. N. Brady: Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus. J Virol, 65 (5), 2612-21 (1991).
145. T. Alefantis, K. Barmak, E. W. Harhaj, C. Grant and B. Wigdahl: Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax. J Biol Chem, 278 (24), 21814-22 (2003). (Pubitemid 36792586)
146. T. Alefantis, K. Mostoller, P. Jain, E. Harhaj, C. Grant and B. Wigdahl: Secretion of the human T cell leukemia virus type I transactivator protein tax. J Biol Chem, 280 (17), 17353-62 (2005). (Pubitemid 41389205)
147. P. Jain, J. Ahuja, Z. K. Khan, S. Shimizu, O. Meucci, S. R. Jennings and B. Wigdahl: Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1. J Leukoc Biol, 82 (1), 44-56 (2007). (Pubitemid 47026415)
148. J. N. Brady: "Extracellular Tax1 protein stimulates NF-kB and expression of NF-kB-responsive Ig kappa and TNF beta genes in lymphoid cells". AIDS Res Hum Retroviruses, 8 (5), 724-7 (1992). (Pubitemid 23130925)
149. P. Ballabh, A. Braun and M. Nedergaard: The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis, 16 (1), 1-13 (2004). (Pubitemid 38569790)
150. R. M. Ransohoff, P. Kivisakk and G. Kidd: Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol, 3 (7), 569-81 (2003). (Pubitemid 37328676)
151. I. A. Romero, M. C. Prevost, E. Perret, P. Adamson, J. Greenwood, P. O. Couraud and S. Ozden: Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol, 74 (13), 6021-30 (2000). (Pubitemid 30412972)
152. J. E. Merrill and E. N. Benveniste: Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci, 19 (8), 331-8 (1996). (Pubitemid 26349062)
153. Y. Kuroda and M. Matsui: Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol, 42 (2), 223-6 (1993). (Pubitemid 23045894)
154. Y. Kuroda, M. Matsui, H. Takashima and K. Kurohara: Granulocyte- macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol, 45 (1-2), 133-6 (1993). (Pubitemid 23224391)
155. N. Nishimoto, K. Yoshizaki, N. Eiraku, K. Machigashira, H. Tagoh, A. Ogata, T. Kuritani, M. Osame and T. Kishimoto: Elevated levels of interleukin- 6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci, 97 (2-3), 183-93 (1990). (Pubitemid 20231238)
156. K. Ohbo, K. Sugamura, T. Sekizawa and K. Kogure: Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy. Neurology, 41 (4), 594-5 (1991).
157. N. Takenouchi, K. Yao and S. Jacobson: Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches. Front Biosci, 9, 2527-39 (2004).
158. B. Asquith and C. R. Bangham: The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. J Theor Biol, 207 (1), 65-79 (2000).
159. E. Hanon, P. Goon, G. P. Taylor, H. Hasegawa, Y. Tanaka, J. N. Weber and C. R. Bangham: High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood, 98 (3), 721-6 (2001).
160. A. M. Vine, A. D. Witkover, A. L. Lloyd, K. J. Jeffery, A. Siddiqui, S. E. Marshall, M. Bunce, N. Eiraku, S. Izumo, K. Usuku, M. Osame and C. R. Bangham: Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis, 186 (7), 932-9 (2002).
161. N. Seki, K. Yamaguchi, A. Yamada, S. Kamizono, S. Sugita, C. Taguchi, M. Matsuoka, H. Matsumoto, S. Nishizaka, K. Itoh and M. Mochizuki: Polymorphism of the 5′-flanking region of the tumor necrosis factor (TNF)- alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. J Infect Dis, 180 (3), 880-3 (1999). (Pubitemid 29411383)
162. J. B. Guerreiro, S. B. Santos, D. J. Morgan, A. F. Porto, A. L. Muniz, J. L. Ho, A. L. Teixeira Jr., M. M. Teixeira and E. M. Carvalho: Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state. Clin Exp Immunol, 145 (2), 296-301 (2006). (Pubitemid 44060120)
163. M. D. Bell, D. D. Taub and V. H. Perry: Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience, 74 (1), 283-92 (1996). (Pubitemid 26291164)
164. M. K. Matyszak, M. J. Townsend and V. H. Perry: Ultrastructural studies of an immune-mediated inflammatory response in the CNS parenchyma directed against a non-CNS antigen. Neuroscience, 78 (2), 549-60 (1997). (Pubitemid 27170344)
165. J. Goverman, A. Woods, L. Larson, L. P. Weiner, L. Hood and D. M. Zaller: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell, 72 (4), 551-60 (1993). (Pubitemid 23077743)
166. S. P. Morrissey, H. Stodal, U. Zettl, C. Simonis, S. Jung, R. Kiefer, H. Lassmann, H. P. Hartung, A. Haase and K. V. Toyka: In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain, 119 ( Pt 1), 239-48 (1996). (Pubitemid 26077568)
167. L. Steinman: A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci U S A, 93 (6), 2253-6 (1996). (Pubitemid 26104336)
168. F. W. Gay, T. J. Drye, G. W. Dick and M. M. Esiri: The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain, 120 ( Pt 8), 1461-83 (1997).
169. P. G. Popovich, P. Wei and B. T. Stokes: Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol, 377 (3), 443-64 (1997). (Pubitemid 27016650)
170. A. K. Stalder, M. J. Carson, A. Pagenstecher, V. C. Asensio, C. Kincaid, M. Benedict, H. C. Powell, E. Masliah and I. L. Campbell: Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol, 153 (3), 767-83 (1998). (Pubitemid 28419031)
171. E. H. Tran, K. Hoekstra, N. van Rooijen, C. D. Dijkstra and T. Owens: Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol, 161 (7), 3767-75 (1998).
172. M. Greter, F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle and B. Becher: Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med, 11 (3), 328-34 (2005). (Pubitemid 40460562)
173. M. K. Matyszak and V. H. Perry: The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience, 74 (2), 599-608 (1996). (Pubitemid 26274227)
174. Y. J. Liu, H. Kanzler, V. Soumelis and M. Gilliet: Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol, 2 (7), 585-9 (2001). (Pubitemid 32677624)
175. M. Pashenkov, Y. M. Huang, V. Kostulas, M. Haglund, M. Soderstrom and H. Link: Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain, 124 (Pt 3), 480-92 (2001). (Pubitemid 32221315)
176. J. Ahuja, V. Lepoutre, B. Wigdahl, Z. K. Khan and P. Jain: Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells. Biomed Pharmacother, 61 (4), 201-8 (2007). (Pubitemid 46705477)
177. K. Mostoller, C. C. Norbury, P. Jain and B. Wigdahl: Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation. J Neurovirol, 10 (6), 358-71 (2004). (Pubitemid 40109623)
178. S. A. Hill, P. A. Lloyd, S. McDonald, J. Wykoff and D. Derse: Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. J Infect Dis, 188 (3), 424-7 (2003). (Pubitemid 36960653)
179. A. Machuca, B. Rodes and V. Soriano: The effect of antiretroviral therapy on HTLV infection. Virus Res, 78 (1- 2), 93-100 (2001). (Pubitemid 32772826)
180. G. P. Taylor, S. E. Hall, S. Navarrete, C. A. Michie, R. Davis, A. D. Witkover, M. Rossor, M. A. Nowak, P. Rudge, E. Matutes, C. R. Bangham and J. N. Weber: Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1- associated myelopathy. J Virol, 73 (12), 10289-95 (1999).
181. R. H. Enting, R. M. Hoetelmans, J. M. Lange, D. M. Burger, J. H. Beijnen and P. Portegies: Antiretroviral drugs and the central nervous system. AIDS, 12 (15), 1941-55 (1998). (Pubitemid 28479270)